Sanofi suffers multiple sclerosis setback


French pharmaceutical Sanofi has run into trouble after the US Food and Drug Administration (FDA) rejected its multiple sclerosis drug Lemtrada (alemtuzumab). The agency said that its rejection of alemtuzumab was the result of poor Phase III clinical trial design and side effects that outweigh the potential benefits.

When Sanofi bought Genzyme for more than $20 billion (£12 billion) in February 2011, additional milestone payments were agreed, depending on the success of alemtuzumab. The monoclonal antibody was approved to treat multiple sclerosis in the EU in September 2013, leading to expectations that the FDA would follow suit in the US.

Without the US market, Lemtrada is very unlikely to meet sales targets, and consequently Sanofi’s share price fell by 1.1%. Furthermore, one US law firm is launching a class action on behalf of investors, claiming the French company made misleading statements about the prospects for alemtuzumab.

In a press release, a spokesperson for Genzyme stated that they strongly disagree with the conclusions and plan to appeal against the FDA’s decision.


Related Content

High hopes

3 February 2015 Feature

news image

Cannabinoids are finally coming out of the shadows and onto the shelves of pharmacies around the globe. Rachel Brazil reports

2012 pharma industry roundup

3 January 2013 Business

news image

What were the bigger stories? And how did the industry fare overall?

Most Read

'Safe antifreeze' works better with added nanoparticles

26 March 2015 Research

news image

Antifreezes based on a non-toxic food additive are now more effective and user-friendly

Simple cooking changes make healthier rice

23 March 2015 Research

news image

Adding oil to water, cooling and reheating rice makes fibre-like resistant starch, reducing calories

Most Commented

Chemists in demand as cannabis industry experiences explosive growth

24 March 2015 News and Analysis

news image

Legalisation of marijuana in some US states is fuelling demand for analytical specialists

Sewage offers attractive source of precious metals

27 March 2015 Research

news image

US Geological Survey team finds valuable metals in treated sewage and is working on the difficult problem of extraction